Cardiovascular adverse events of ibrutinib

被引：14
|
作者：
Ahn, Inhye E. [1 ]
机构：
[1] NHLBI, Bldg 10, Bethesda, MD 20892 USA
来源：
BLOOD | 2019年 / 134卷 / 22期
关键词：
D O I：
10.1182/blood.2019002805
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Dickerson et al report on the increased incidence and worsening severity of hypertension and its association with cardiovascular outcomes in 562 patients treated with ibrutinib for B-cell malignancies.(1)
引用
收藏
页码：1881 / 1882
页数：2
相关论文
共 50 条
  • [41] Adverse Cardiovascular Events in Cancer Trials Missing in Action?
    Bishopric, Nanette H.
    Lippman, Marc E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (06) : 629 - 631
  • [42] Adverse cardiovascular events after cancer in Queensland, Australia
    Diaz, Abbey
    Cunningham, Joan
    Lindsay, Daniel
    Callander, Emily
    Sverdlov, Aaron
    Shaw, Joanne
    Griffiths, Kalinda
    Garvey, Gail
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50
  • [43] GLOMERULAR HYPERFILTRATION IS AND INDEPENDENT PREDICTOR OF ADVERSE CARDIOVASCULAR EVENTS
    Fiorucci, Gioia
    Palatini, Paolo
    Signorotti, Sara
    Selvi, Antonio
    Verdecchia, Paolo
    Reboldi, Gianpaolo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 330 - 330
  • [44] Adverse Cardiovascular Events Following Severe Maternal Morbidity
    Cartus, Abigail R.
    Jarlenski, Marian P.
    Himes, Katherine P.
    James, Alton Everette
    Naimi, Ashley, I
    Bodnar, Lisa M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2022, 191 (01) : 126 - 136
  • [45] Adverse Cardiovascular Events In Patients With Psoriasis And Psoriatic Arthritis
    Ottensoser, Molly
    Berger, Jeffrey
    Garshick, Michael S.
    CIRCULATION, 2022, 145
  • [46] JAK inhibitors: risk of major adverse cardiovascular events
    Reactions Weekly, 2025, 2052 (1) : 8 - 8
  • [47] Cardiovascular and Metabolic Comorbidities as the Factors for Adverse Events With Ketamine
    Sadko, Krzysztof
    Jakuszkowiak-Wojten, Katarzyna
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (04) : 393 - 394
  • [48] Prediabetes as a risk factor for major adverse cardiovascular events
    Mando, Ramy
    Waheed, Muhammad
    Michel, Adrian
    Karabon, Patrick
    Halalau, Alexandra
    ANNALS OF MEDICINE, 2021, 53 (01) : 2090 - 2098
  • [49] Adverse Cardiovascular Events during Treatment with Pioglitazone and Rosiglitazone
    Juurlink, David N.
    Gomes, Tara
    Lipscombe, Lorraine L.
    Austin, Peter C.
    Hux, Jan E.
    Mamdani, Muhammad M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S194 - S194
  • [50] Electrocardiographic Predictors of Adverse Cardiovascular Events in Suspected Poisoning
    Manini A.F.
    Nelson L.S.
    Skolnick A.H.
    Slater W.
    Hoffman R.S.
    Journal of Medical Toxicology, 2010, 6 (2) : 106 - 115
12345